[Myocardial Infarction in the Group of Patients With Atrial Fibrillation]

Area of Science:

• Cardiology
• Clinical Medicine
• Internal Medicine

Background:

• The co-occurrence of myocardial infarction (MI) and atrial fibrillation (AF) is increasing annually.
• Patients with both MI and AF constitute a high-risk group demanding specialized clinical management.
• Understanding the interplay between these conditions is crucial for effective patient care.

Purpose of the Study:

• To elucidate the mechanisms underlying the interaction between atrial fibrillation and myocardial infarction.
• To explore specific prediction aspects based on the types of AF and MI.
• To address the complexities of antithrombotic therapy in patients with concomitant MI and AF.

Main Methods:

• Literature review focusing on the pathophysiology of AF and MI.
• Analysis of diagnostic criteria for AF-associated embolic myocardial infarction.
• Evaluation of current therapeutic strategies, including antithrombotic regimens.

Main Results:

• Identification of specific mechanisms driving the interaction between AF and MI.
• Delineation of predictive factors influenced by the subtypes of AF and MI.
• Establishment of diagnostic criteria for a distinct category of AF-associated, embologenic MIs.
• Recommendations for tailored therapeutic regimens for this high-risk patient cohort.

Conclusions:

• The co-existence of AF and MI presents unique clinical challenges requiring a multifaceted approach.
• Specific diagnostic criteria and targeted antithrombotic therapies are essential for managing AF-associated embolic MIs.
• Further research into the intricate mechanisms and optimal management strategies is warranted.